Comments

Regenxbio Stock Price, Quotes and Forecasts

Q: What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RGNXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$8.70

0.000.00%

Pre-Market: 4:00 PM EDT

Regenxbio (RGNX) Forecast

News Earnings Regenxbio (RGNX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Regenxbio Stock Price, Quotes and Forecasts | NASDAQ:RGNX | Benzinga

Explore Regenxbio stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for RGNX.

Open	-
Close	-
Volume / Avg.	36.00 / 1.02M
Day Range	- - -
52 Wk Range	5.62 - 22.84
Market Cap	$435.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	16.34%
Days to Cover	8.38

Recent News

Regenxbio Touts Positive Biomarker Data From Duchenne Muscular Dystrophy Gene Therapy Trial

Regenxbio's RGX-202 gene therapy shows promising results in Duchenne muscular dystrophy, with high microdystrophin levels and a well-tolerated safety profile.

Vandana Singh

Signet Jewelers, BGM Group, StoneCo, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

Avi Kapoor

Semtech Posts Better-Than-Expected Earnings, Joins Rubrik, DocuSign, PagerDuty And Other Big Stocks Moving Higher On Friday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	36.00 / 1.02M
Day Range	- - -
52 Wk Range	5.62 - 22.84
Market Cap	$435.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	16.34%
Days to Cover	8.38

About Regenxbio Inc

Sector

Health Care

Industry

Biotechnology

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Regenxbio (RGNX) stock?

You can purchase shares of Regenxbio (NASDAQ:RGNX) through any online brokerage.

View our list of the best stock brokerages

Who are Regenxbio (RGNX) competitors?

Other companies in Regenxbio’s space includes: Tectonic Therapeutic (NASDAQ:TECX), Humacyte (NASDAQ:HUMA), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC) and Altimmune (NASDAQ:ALT).

What is the forecast, or price target, for Regenxbio (RGNX) stock?

Regenxbio has a consensus price target of $35.31.

What is the current price for Regenxbio (RGNX)?

The stock price for Regenxbio (NASDAQ: RGNX) is $8.7 last updated March 24, 2025 at 4:00 PM EDT.

Does Regenxbio (RGNX) pay a dividend?

There are no upcoming dividends for Regenxbio.

When is Regenxbio (NASDAQ:RGNX) reporting earnings?

Regenxbio’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is Regenxbio (RGNX) going to split?

There is no upcoming split for Regenxbio.

What sector and industry does Regenxbio (RGNX) operate in?

Regenxbio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.